These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 34384806)
1. Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference. Hicks CW; Clark TWI; Cooper CJ; de Bhailís ÁM; De Carlo M; Green D; Małyszko J; Miglinas M; Textor SC; Herzog CA; Johansen KL; Reinecke H; Kalra PA Am J Kidney Dis; 2022 Feb; 79(2):289-301. PubMed ID: 34384806 [TBL] [Abstract][Full Text] [Related]
2. Pathogenesis and management of renovascular hypertension and ischemic nephropathy. Yerram P; Karuparthi PR; Chaudhary K Minerva Urol Nefrol; 2012 Mar; 64(1):63-72. PubMed ID: 22402318 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology and optimal management in patients with renal artery stenosis. Piecha G; Wiecek A; Januszewicz A J Nephrol; 2012; 25(6):872-8. PubMed ID: 23023722 [TBL] [Abstract][Full Text] [Related]
4. Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH). Sarafidis PA; Theodorakopoulou M; Ortiz A; Fernandez-Fernández B; Nistor I; Schmieder R; Arici M; Saratzis A; Van der Niepen P; Halimi JM; Kreutz R; Januszewicz A; Persu A; Cozzolino M Nephrol Dial Transplant; 2023 Nov; 38(12):2835-2850. PubMed ID: 37202218 [TBL] [Abstract][Full Text] [Related]
5. Improving outcomes in atherosclerotic renovascular disease: importance of clinical presentation and multi-disciplinary review. de Bhailis ÁM; Lake E; Chrysochou C; Green D; Chinnadurai R; Kalra PA J Nephrol; 2024 May; 37(4):1093-1105. PubMed ID: 38594599 [TBL] [Abstract][Full Text] [Related]
6. Endovascular Versus Medical Management of Atherosclerotic Renovascular Disease: Update and Emerging Concepts. Pappaccogli M; Robberechts T; Lengelé JP; Van der Niepen P; Sarafidis P; Rabbia F; Persu A Hypertension; 2023 Jun; 80(6):1150-1161. PubMed ID: 36919595 [TBL] [Abstract][Full Text] [Related]
8. The role of the renin-angiotensin-aldosterone system in renal artery stenosis, renovascular hypertension, and ischemic nephropathy: diagnostic implications. Covic A; Gusbeth-Tatomir P Prog Cardiovasc Dis; 2009; 52(3):204-8. PubMed ID: 19917331 [TBL] [Abstract][Full Text] [Related]
11. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period. Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553 [TBL] [Abstract][Full Text] [Related]
12. Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension. Khangura KK; Eirin A; Kane GC; Misra S; Textor SC; Lerman A; Lerman LO J Hypertens; 2014 Jun; 32(6):1300-6. PubMed ID: 24625655 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous Revascularization for Atherosclerotic Renal Artery Stenosis: A Meta-Analysis of Randomized Controlled Trials. Zhu Y; Ren J; Ma X; Chen MH; Zhou Y; Jin M; Liu Z Ann Vasc Surg; 2015 Oct; 29(7):1457-67. PubMed ID: 26173202 [TBL] [Abstract][Full Text] [Related]